Shannon Lantzy MedCrypt New VP of Consulting

Lantzy Will Leverage Her Regulatory Science & Business Transformation Experience fron Working with Booz Allen Hamilton, the FDA, & NASA to Launch MedCrypt's Consulting Services

MedCrypt the proactive cybersecurity solution provider for medical devices, today announced the addition of Shannon Lantzy, Ph.D., as their new Vice President of Consulting.

Prior to joining MedCrypt, Shannon Lantzy spent six years with Booz Allen Hamilton where she led the Regulatory Science Innovation team, partnering with the U.S. Food and Drug Administration (FDA) to develop, test, and evaluate new approaches to regulatory decisions and benefit-risk assessments.

Shannon Lantzy also co-founded Booz Allen’s Secure Connected Health practice and brought together a diverse set of experts, cybersecurity tools, and strategies to solve cybersecurity challenges relating to patient safety. Before Booz Allen, Lantzy was a consultant for NASA, helping with organizational strategy, capability assessment, enterprise architecture, technology adoption, and process improvement. Lantzy earned a Ph.D. in Information Systems from Robert H. Smith School of Business at the University of Maryland.

“Advancements in connected technology have paved the way for a future of healthcare that is digital and delivered in new environments,” said Shannon Lantzy, MedCrypt Vice President of Consulting. “To build this digital landscape and to support future innovation, healthcare needs a baseline of secure infrastructure. The MedCrypt team is working with some of the world’s largest medical device manufacturers to improve their medical device security posture and I am both eager and proud to join in on their efforts.”

At MedCrypt, Shannon Lantzy will be responsible for leading MedCrypt’s Consulting Services to bring clinically innovative medical devices that are secure by design through their lifecycle. She will lead and support consulting engagements, ensuring MedCrypt’s customers meet their business outcomes and the pre-and post-market cybersecurity guidelines from the FDA.

“I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future,” said Mike Kijewski, CEO of MedCrypt. “We’re excited to have Shannon join our team to help our customers transform from reactive to proactive product security.”

SourceMedCrypt

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.